Phenomics Health Inc.
Phenomics Health is a pioneering precision medicine company dedicated to personalizing medication treatment through advanced pharmacogenomic and pharmacometabolomic methods. They focus on predicting the right drug and dose for various medical conditions, measuring medications in circulation, and understanding patient-specific factors to improve outcomes, reduce adverse reactions, and optimize therapy. Their innovative platform integrates genetic, biological, demographic, clinical, sociological, and environmental data to deliver highly accurate, personalized drug response predictions and recommendations.
Industries
Nr. of Employees
small (1-50)
Phenomics Health Inc.
Plymouth, Michigan, United States, North America
Products
Pharmacogenomic panel (provider genomic report)
Clinical pharmacogenomic panel analyzing multiple genes and regulatory variants to inform prescribing across CNS, cardiovascular, metabolic and other therapeutic areas; sample collection via buccal swab.
Medication identification panel (binary detection, ~211 compounds)
Point-of-care fingerstick test that provides binary identification (+/-) of a broad panel of medications and OTCs and flags major drug interactions for multimorbid patients.
Behavioral-health medication quantitation panel (~87 compounds)
Assay focused on behavioral-health-related medications and OTCs that provides quantitative drug level information to enable dose optimization in psychiatry and chronic pain.
Comprehensive quantitative medication panel (232+ analytes)
Extensive quantitative assay covering hundreds of medications/analytes to support dose optimization and monitoring for metabolic, cardiovascular, pain, and psychiatric indications.
Pharmacogenomic panel (provider genomic report)
Clinical pharmacogenomic panel analyzing multiple genes and regulatory variants to inform prescribing across CNS, cardiovascular, metabolic and other therapeutic areas; sample collection via buccal swab.
Medication identification panel (binary detection, ~211 compounds)
Point-of-care fingerstick test that provides binary identification (+/-) of a broad panel of medications and OTCs and flags major drug interactions for multimorbid patients.
Behavioral-health medication quantitation panel (~87 compounds)
Assay focused on behavioral-health-related medications and OTCs that provides quantitative drug level information to enable dose optimization in psychiatry and chronic pain.
Comprehensive quantitative medication panel (232+ analytes)
Extensive quantitative assay covering hundreds of medications/analytes to support dose optimization and monitoring for metabolic, cardiovascular, pain, and psychiatric indications.
Services
Clinical pharmacogenomic testing service
Provider-facing pharmacogenomic testing and analysis using buccal swabs or genomic samples to report gene-drug associations and prescribing guidance across therapeutic areas.
Pharmacometabolomic medication measurement service
Point-of-care fingerstick or lab blood testing to identify and/or quantify circulating medications and OTCs, reconcile with EMR, and detect drug-drug interactions and adherence issues.
Contract research and collaborative testing
Research services to test mechanisms, pathways, and biomarker applications for drug development and repurposing across CNS, cardiovascular, oncology, GI, and immune system disorders.
Clinical reporting and decision-support delivery
Delivery of clinical reports that reconcile measured exposures with records, identify interactions, and provide dose-tailoring recommendations to inform prescribing.
Prior-authorization and billing support
Operational support for insurance billing, claim submission, and optional prior-authorization automation through third-party integration.
Clinical pharmacogenomic testing service
Provider-facing pharmacogenomic testing and analysis using buccal swabs or genomic samples to report gene-drug associations and prescribing guidance across therapeutic areas.
Pharmacometabolomic medication measurement service
Point-of-care fingerstick or lab blood testing to identify and/or quantify circulating medications and OTCs, reconcile with EMR, and detect drug-drug interactions and adherence issues.
Contract research and collaborative testing
Research services to test mechanisms, pathways, and biomarker applications for drug development and repurposing across CNS, cardiovascular, oncology, GI, and immune system disorders.
Clinical reporting and decision-support delivery
Delivery of clinical reports that reconcile measured exposures with records, identify interactions, and provide dose-tailoring recommendations to inform prescribing.
Prior-authorization and billing support
Operational support for insurance billing, claim submission, and optional prior-authorization automation through third-party integration.
Expertise Areas
- Pharmacogenomics and genomic variant interpretation
- Pharmacometabolomics and therapeutic drug monitoring
- Bioinformatics and AI-driven phenotype prediction
- Clinical laboratory testing and validation
Key Technologies
- Whole and partial genomic sequencing and variant analysis
- Analysis of non-coding/regulatory genomic variants
- Pharmacometabolomic quantitation of circulating drugs
- AI and machine learning for phenotype prediction